Bhavsar D. Adverse Event Label Expansion for GLP-1 Medications Due toOff-‎Label Use: Regulatory Implications and Challenges. IJBAS [Internet]. 2026 May 19 [cited 2026 Jun. 13];14(8):702-9. Available from: https://www.sciencepubco.com/index.php/IJBAS/article/view/37690